ProPhase Labs, Inc. Financing Cash Flow
ProPhase Labs, Inc. (PRPH) reported Financing Cash Flow of $744.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-19
- ProPhase Labs, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $67.00K, a 74.33% decline year-over-year.
- ProPhase Labs, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $677.00K, a 65.07% decline year-over-year.
- ProPhase Labs, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $915.00K, a 75.50% decline year-over-year.
- ProPhase Labs, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $3.72M, a 30.32% increase year-over-year.
- ProPhase Labs, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $6.84M, a 51.81% decline from fiscal 2024.
- ProPhase Labs, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $14.19M, a 146.40% increase from fiscal 2023.
- ProPhase Labs, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $5.76M.
- ProPhase Labs, Inc. net cash provided by (used in) financing activities for fiscal 2022 was -$26.02M, a 174.08% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $67.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-08-19 | $744.00K 10-Q · filed 2026-08-19 | $1.66M derived: sum of 3 quarters · filed 2026-08-19 | $5.38M derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $677.00K 10-Q/A · filed 2026-07-09 | $1.59M derived: sum of 2 quarters · filed 2026-07-09 | $5.31M derived: sum of 3 quarters · filed 2026-07-09 | $5.58M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $915.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | $4.64M derived: sum of 2 quarters · filed 2026-06-01 | $4.90M derived: sum of 3 quarters · filed 2026-08-19 | $6.84M 10-K · filed 2026-06-01 |
| 2025-09-30 | $3.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $3.98M derived: sum of 2 quarters · filed 2026-08-19 | $5.92M 10-Q · filed 2025-11-19 | $9.66M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $261.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-08-19 | $2.20M 10-Q · filed 2026-08-19 | $5.93M derived: sum of 3 quarters · filed 2026-08-19 | $8.79M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $1.94M 10-Q/A · filed 2026-07-09 | $5.67M derived: sum of 2 quarters · filed 2026-07-09 | $8.53M derived: sum of 3 quarters · filed 2026-07-09 | $13.85M derived: sum of 4 quarters · filed 2026-07-09 |
| 2024-12-31 | $3.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | $6.59M derived: sum of 2 quarters · filed 2026-06-01 | $11.91M derived: sum of 3 quarters · filed 2026-06-01 | $14.19M 10-K · filed 2026-06-01 |
| 2024-09-30 | $2.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $8.18M derived: sum of 2 quarters · filed 2025-11-19 | $10.45M 10-Q · filed 2025-11-19 | $13.37M derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | $5.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $7.59M 10-Q · filed 2025-08-13 | $10.52M derived: sum of 3 quarters · filed 2025-08-13 | $11.72M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $2.27M 10-Q · filed 2025-05-20 | $5.20M derived: sum of 2 quarters · filed 2025-05-20 | $6.39M derived: sum of 3 quarters · filed 2025-05-20 | $6.35M derived: sum of 4 quarters · filed 2025-05-20 |
| 2023-12-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $4.12M derived: sum of 2 quarters · filed 2025-04-01 | $4.08M derived: sum of 3 quarters · filed 2025-04-01 | $5.76M 10-K · filed 2025-04-01 |
| 2023-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $1.15M derived: sum of 2 quarters · filed 2024-11-13 | $2.83M 10-Q · filed 2024-11-13 | -$6.67M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.63M 10-Q · filed 2024-08-14 | -$7.87M derived: sum of 3 quarters · filed 2024-08-14 | -$10.99M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $1.68M 10-Q · filed 2024-05-10 | -$7.82M derived: sum of 2 quarters · filed 2024-05-10 | -$10.94M derived: sum of 3 quarters · filed 2024-05-10 | -$17.12M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$12.62M derived: sum of 2 quarters · filed 2024-03-29 | -$18.80M derived: sum of 3 quarters · filed 2024-03-29 | -$26.02M 10-K · filed 2024-03-29 |
| 2022-09-30 | -$3.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$9.30M derived: sum of 2 quarters · filed 2023-11-13 | -$16.52M 10-Q · filed 2023-11-13 | -$17.49M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$6.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$13.40M 10-Q · filed 2023-08-11 | -$14.37M derived: sum of 3 quarters · filed 2023-08-11 | -$14.37M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$7.22M 10-Q · filed 2023-05-12 | -$8.18M derived: sum of 2 quarters · filed 2023-05-12 | -$8.18M derived: sum of 3 quarters · filed 2023-05-12 | -$12.73M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$962.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$962.00K derived: sum of 2 quarters · filed 2023-03-29 | -$5.51M derived: sum of 3 quarters · filed 2023-03-29 | $35.13M 10-K · filed 2023-03-29 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$4.55M derived: sum of 2 quarters · filed 2022-11-10 | $36.09M 10-Q · filed 2022-11-10 | $36.16M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$4.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $36.09M 10-Q · filed 2022-08-12 | $36.16M derived: sum of 3 quarters · filed 2022-08-12 | |
| 2021-03-31 | $40.63M 10-Q · filed 2022-05-13 | $40.70M derived: sum of 2 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $9.99M 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $9.92M 10-Q · filed 2021-11-12 | |||
| 2019-12-31 | -$2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$2.89M derived: sum of 2 quarters · filed 2021-03-31 | -$2.89M derived: sum of 3 quarters · filed 2021-03-31 | -$5.82M 10-K · filed 2021-03-31 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-19 | $0.00 derived: sum of 2 quarters · filed 2020-11-19 | -$2.93M 10-Q · filed 2020-11-19 | -$2.93M derived: sum of 4 quarters · filed 2020-11-19 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$2.93M 10-Q · filed 2020-08-11 | -$2.93M derived: sum of 3 quarters · filed 2020-08-11 | -$2.93M derived: sum of 4 quarters · filed 2020-08-11 |
| 2019-03-31 | -$2.93M 10-Q · filed 2020-05-12 | -$2.93M derived: sum of 2 quarters · filed 2020-05-12 | -$2.93M derived: sum of 3 quarters · filed 2020-05-12 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $0.00 derived: sum of 2 quarters · filed 2020-03-26 | -$11.36M 10-K · filed 2020-03-26 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$11.36M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | -$11.36M 10-Q · filed 2019-08-12 | |||
| 2017-12-31 | -$3.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$13.02M derived: sum of 2 quarters · filed 2019-03-26 | -$14.77M derived: sum of 3 quarters · filed 2019-03-26 | -$16.20M 10-K · filed 2019-03-26 |
| 2017-09-30 | -$9.19M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2018-11-14 | -$10.95M derived: sum of 2 quarters · filed 2018-11-14 | -$12.38M 10-Q · filed 2018-11-14 | |
| 2017-06-30 | -$1.76M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-08-20 | -$3.19M 10-Q/A · filed 2018-08-20 | ||
| 2017-03-31 | -$1.43M 10-Q/A · filed 2018-08-20 | |||
| 2016-12-31 | -$100.00K 10-K/A · filed 2018-08-20 | |||
| 2015-12-31 | $1.38M derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-08-20 | $2.42M derived: sum of 2 quarters · filed 2018-08-20 | $2.94M 10-K/A · filed 2018-08-20 | |
| 2015-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $1.56M 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | $524.00K 10-Q · filed 2016-08-11 | |||
| 2014-12-31 | -$99.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | -$16.00K derived: sum of 2 quarters · filed 2017-02-24 | $4.81M 10-K · filed 2017-02-24 | |
| 2014-09-30 | $83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $4.91M 10-Q · filed 2015-11-13 | ||
| 2014-06-30 | $4.83M 10-Q · filed 2015-08-12 | |||
| 2013-12-31 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $176.00K derived: sum of 2 quarters · filed 2016-03-29 | $176.00K derived: sum of 3 quarters · filed 2016-03-29 | $371.00K 10-K · filed 2016-03-29 |
| 2013-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $27.00K derived: sum of 2 quarters · filed 2013-11-13 | $222.00K 10-Q · filed 2013-11-13 | $1.29M derived: sum of 4 quarters · filed 2013-11-13 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $195.00K 10-Q · filed 2013-08-13 | $1.26M derived: sum of 3 quarters · filed 2013-08-13 | $1.26M derived: sum of 4 quarters · filed 2013-11-13 |
| 2013-03-31 | $195.00K 10-Q · filed 2013-05-10 | $1.26M derived: sum of 2 quarters · filed 2013-05-10 | $1.26M derived: sum of 3 quarters · filed 2013-11-13 | $1.26M derived: sum of 4 quarters · filed 2013-11-13 |
| 2012-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $1.07M derived: sum of 2 quarters · filed 2013-11-13 | $1.07M derived: sum of 3 quarters · filed 2013-11-13 | $1.07M 10-K · filed 2013-03-28 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $0.00 derived: sum of 2 quarters · filed 2013-11-13 | $0.00 10-Q · filed 2013-11-13 | $0.00 derived: sum of 4 quarters · filed 2013-11-13 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $0.00 10-Q · filed 2013-08-13 | $0.00 derived: sum of 3 quarters · filed 2013-08-13 | -$449.00K derived: sum of 4 quarters · filed 2013-08-13 |
| 2012-03-31 | $0.00 10-Q · filed 2013-05-10 | $0.00 derived: sum of 2 quarters · filed 2013-05-10 | -$449.00K derived: sum of 3 quarters · filed 2013-05-10 | |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$449.00K derived: sum of 2 quarters · filed 2013-03-28 | -$449.00K 10-K · filed 2013-03-28 | |
| 2011-09-30 | -$449.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$449.00K 10-Q · filed 2012-11-14 | ||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-12 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $0.00 derived: sum of 2 quarters · filed 2013-03-28 | $133.00K 10-K · filed 2013-03-28 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $133.00K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $133.00K 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | $127.00K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |